Log in or Sign up for Free to view tailored content for your specialty!
Diabetes News
Digital access key to boosting diabetes self-management education uptake for older adults
More than one-third of older adults with diabetes lack the digital tools necessary for virtual diabetes self-management education, and providers can play a role in promoting digital inclusion, according to a speaker.
Semaglutide cuts risk for worsening heart failure, CV death among adults with HFpEF
Semaglutide cut the risk for worsening heart failure and CV death for adults with HF with preserved ejection fraction, according to data presented at the European Society of Cardiology Congress and simultaneously published in The Lancet.
Log in or Sign up for Free to view tailored content for your specialty!
Providers should assess HbA1c and CGM metrics in diabetes management
Both HbA1c and continuous glucose monitoring metrics have limitations, and providers should not rely on a single metric for managing a patient’s diabetes, according to two speakers.
CGM use in early pregnancy offers ‘window of opportunity’ to improve perinatal outcomes
Women with fetal overgrowth or hypertensive disorders of pregnancy have notable continuous glucose monitor-derived glycemic patterns detected during early pregnancy, sometimes without a gestational diabetes diagnosis, researchers reported.
Finerenone improves outcomes in patients with mildly reduced, preserved ejection fraction
In patients with heart failure and mildly reduced or preserved ejection fraction, finerenone reduced risk for CV death and worsening HF by 16% compared with placebo, researchers reported at the European Society of Cardiology Congress.
Choice to halt RAS therapy before major surgery can be left to patient, physician
Discontinuation of renin-angiotensin system inhibitor therapy before major noncardiac surgery did not appear to affect postoperative outcomes vs. treatment continuation, a speaker reported.
Wegovy likely not cost-effective in the SELECT trial population
Researchers estimate that semaglutide 2.4 mg is not cost-effective for secondary CVD prevention for patients with overweight or obesity without diabetes, according to an Australian study.
Care partners of deaf and hard-of-hearing people with diabetes face unique challenges
Care partners of deaf and hard-of-hearing people with diabetes face several communication-related challenges that could be addressed through a specialized training program, according to two presenters.
GLP-1s may improve outcomes when added to SGLT2 therapy for HFpEF, diabetes and obesity
GLP-1 receptor agonist use on top of SGLT2 inhibition in patients with HF with preserved ejection fraction, type 2 diabetes and obesity was associated with reduced risk for adverse events vs. SGLT2 inhibition alone, researchers reported.
Multiple implementation methods can assist primary care practices with CGM use
Primary care practices can successfully implement continuous glucose monitoring for patients with diabetes by using American Academy of Family Physicians resources or a virtual CGM initiation service, according to two speakers.
-
Headline News
WikiGuidelines group publishes first new UTI guidance in 14 years
November 11, 20243 min read -
Headline News
Q&A: Industrial fires present unique respiratory health risks
November 11, 20244 min read -
Headline News
Physicians encouraged to conduct oral food challenges for infants, toddlers
November 12, 20247 min read
-
Headline News
WikiGuidelines group publishes first new UTI guidance in 14 years
November 11, 20243 min read -
Headline News
Q&A: Industrial fires present unique respiratory health risks
November 11, 20244 min read -
Headline News
Physicians encouraged to conduct oral food challenges for infants, toddlers
November 12, 20247 min read